Abstract:This comprehensive review delves into the rapidly evolving arena of cancer vaccines. Initially, we examine the intricate constitution of the tumor microenvironment (TME), a dynamic factor that significantly influences tumor heterogeneity. Current research trends focusing on harnessing the TME for effective tumor vaccine treatments are also discussed. We then provide a detailed overview of the current state of research concerning tumor immunity and the mechanisms of tumor vaccines, describing the complex immunological processes involved. Furthermore, we conduct an exhaustive analysis of the contemporary research landscape of tumor vaccines, with a particular focus on peptide vaccines, DNA/RNA-based vaccines, viral-vector-based vaccines, dendritic-cell-based vaccines, and whole-cell-based vaccines. We analyze and summarize these categories of tumor vaccines, highlighting their individual advantages, limitations, and the factors influencing their effectiveness. In our survey of each category, we summarize commonly used tumor vaccines, aiming to provide readers with a more comprehensive understanding of the current state of tumor vaccine research. We then delve into an innovative strategy combining cancer vaccines with other therapies. By studying the effects of combining tumor vaccines with immune checkpoint inhibitors, radiotherapy, chemotherapy, targeted therapy, and oncolytic virotherapy, we establish that this approach can enhance overall treatment efficacy and offset the limitations of single-treatment approaches, offering patients more effective treatment options. Following this, we undertake a meticulous analysis of the entire process of personalized cancer vaccines, elucidating the intricate process from design, through research and production, to clinical application, thus helping readers gain a thorough understanding of its complexities. In conclusion, our exploration of tumor vaccines in this review aims to highlight their promising potential in cancer treatment. As research in this field continues to evolve, it undeniably holds immense promise for improving cancer patient outcomes.

Bidirectional Crosstalk Between Therapeutic Cancer Vaccines and the Tumor Microenvironment: Beyond Tumor Antigens

Therapeutic cancer vaccines: advancements, challenges, and prospects

Cytokines and soluble mediators as architects of tumor microenvironment reprogramming in cancer therapy

Turning the corner on therapeutic cancer vaccines

Therapeutic Vaccines for Cancer Immunotherapy

Role of tumor microenvironment in cancer progression and therapeutic strategy

Navigating the Immune Maze: Pioneering Strategies for Un-shackling Cancer Immunotherapy Resistance

Immune resistance orchestrated by the tumor microenvironment

Advances in Therapeutic Cancer Vaccines, Their Obstacles, and Prospects Toward Tumor Immunotherapy

Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy

Manipulation of the crosstalk between tumor angiogenesis and immunosuppression in the tumor microenvironment: Insight into the combination therapy of anti-angiogenesis and immune checkpoint blockade

Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment

Challenges and New Directions in Therapeutic Cancer Vaccine Development

Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy

Exposure of Immunogenic Tumor Antigens in Surrendered Immunity and the Significance of Autologous Tumor Cell-Based Vaccination in Precision Medicine

Tumor Vaccines: Unleashing the Power of the Immune System to Fight Cancer

The Role of Traditional Chinese Medicine in Cancer Immunotherapy: Current Status and Future Directions.

A recent perspective on designing tumor vaccines for tumor immunology

Recent Progress on Therapeutic Vaccines for Breast Cancer

Advances in therapeutic cancer vaccines: harnessing immune adjuvants for enhanced efficacy and future perspectives

Cancer immunotherapies: advances and bottlenecks.